Although its exact mechanism in the treatment of partial-onset seizures is unknown, cenobamate has been shown to reduce repetitive neuronal firing by inhibiting voltage-gated sodium currents. The Food ...

Sunovion announced that it has submitted a supplemental New Drug Application (sNDA) to the Food and Drug Administration (FDA) for Aptiom (eslicarbazepine acetate) as monotherapy treatment of ...

Sunovion Pharmaceuticals Inc. of Marlborough has submitted a supplemental new drug application to the Food and Drug Administration. The application seeks approval for the use of Aptiom for monotherapy ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The FDA has granted approval to Azurity Pharmaceuticals ...

Dec. 12, 2002 — At the 56th annual meeting of the American Epilepsy Society, three reports of open-label testing of oxcarbazepine (Trileptal) suggest that the drug is safe and effective in adults and ...

This new approval provides clinicians with the option to prescribe VIMPAT to their pediatric patients either as an oral solution or a convenient tablet. 1 This allows for flexible administration ...

Treatment approved for patients whose seizures are still uncontrolled with first adjunctive therapy The All Wales Medicines Strategy Group (AWMSG) has issued a Final Appraisal Recommendation (FAR) on ...

child yellow pill medicine Safety data for Fycompa was consistent with the safety profile in adult populations without the need for weight-based dosing. The Food and Drug Administration has expanded ...

Research Triangle Park, NC (January 20, 2002) – GlaxoSmithKline announced today that the U.S. Food and Drug Administration (FDA) granted marketing clearance for Lamictal® (lamotrigine) Tablets as ...

The treatment of epilepsy relies primarily on antiepileptic medications, which control seizures in approximately two thirds of patients. Other proven therapeutic modalities include epilepsy surgery, ...

According to the Centers for Disease Control and Prevention (CDC), about 1 out of 10 people will have a seizure during their lifetime. Most of these seizures will be epileptic seizures, which are ...

The U.S. Food and Drug Administration yesterday approved Briviact (brivaracetam) as an add-on treatment to other medications to treat partial onset seizures in patients age 16 years and older with ...